Ozagrel hydrochloride (Standard)

Overview

Ozagrel hydrochloride (Standard) is the analytical reference standard of Ozagrel hydrochloride ( HY-B0428B ). Ozagrel hydrochloride (OKY-046 hydrochloride) is a high selective and orally active thromboxane A 2 (TXA 2 ) synthase inhibitor with an IC 50 of 11 nM. Ozagrel hydrochloride exerts anti-platelet aggregation, vasodilation and anti-inflammatory effects by inhibiting the production of TXA 2 and increasing the production of prostacyclin (PGI2) . Ozagrel hydrochloride can be used for the study of ischemic stroke, asthma and thromboembolic diseases.

Application

Products | Products > Disease Areas > Neurological, Eye or Ear Disease | Products > Disease Areas > Inflammation or Immune System Disease | Products > Disease Areas > Blood or Cardio-cerebrovascular Disease | Products > Signaling Pathways > Others | Products > Signaling Pathways > GPCR/G Protein | Products > Research Areas > Inflammation/Immunology | Products > Research Areas > Cardiovascular Disease | Products > Research Areas > Neurological Disease | Products > Signaling Pathways > Reference Standards | Products > Signaling Pathways > Prostaglandin Receptor

Product Information

• Catalog No.: HY-B0428BR
• CAS No.: 78712-43-3
• Molecular Formula: C13H13ClN2O2
• Molecular Weight: 264.71
• Purity: 98%
• Storage: Please store the product under the recommended conditions in the Certificate of Analysis.
• Availability: In-stock

Source

Original product source